암 환자의 경구용 항암제 복용이행 영향요인

키워드

참고문헌 (30)

1. Banna GL, "Anticancer oral therapy : Emerging related issues", Cancer Treat Rev, 36(8), pp.595~605 (2010)
2. Regnier Denois V, "Adherence with oral chemotherapy : results from a qualitative study of the behaviour and representations of patients and oncologists", Eur J Cancer Care(Engl), 20(4), pp.520~527 (2011)
3. Benjamin L, "Physicians’ preferences for prescribing oral and intravenous anticancer drugs : a Discrete Choice Experiment", Eur J Cancer, 48(6), pp.912~920 (2012)
4. Hartigan K, "Patient education: the cornerstone of successful oral chemotherapy treatment", Clin J Oncol Nurs, 7(6), pp.21~24 (2003)
5. Moore S, "Facilitating oral chemotherapy treatment and compliance through patient", family-focused education, 2007, pp.30(2), 112~122
6. Foulon V, "Patient adherence to oral anticancer drugs : an emerging issue in modern oncology", Acta Clinica Belgica, 66(2), pp.85~96 (2012)
7. "Adherence to long-term therapies: evidence for actions. Geneva, WHO"[URL]
8. Ruddy K, "Patient adherence and persistence with oral anticancer treatment", CA Cancer J Clin, 59(1), pp.56~66 (2009)
9. Verbrugghe M, "Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs : a systematic review", Cancer Treat Rev, 39(6), pp.610~621 (2013)
10. Gater A, "Adherence to oral tyrosine kinase inhibitor therapies in chronic myeloid leukemia", Leukemia Research, 36, pp.817~825 (2012)
11. Marques PAC, "Factors that affect cancer patient compliance to oral anti-neoplastic therapy", Acta Paul Enferm, 21(2), pp.323~329 (2008)
12. Banning M, "Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review", Eur J Cancer Care(Engl), 21(1), pp.10~19 (2012)
13. Jabbour EJ, "Megan Cornelison A, Marin D. Patient adherence to tyrosine kinase inhibitor therapy in chronic myeloid leukemia", Am J Hematol, 87(7), pp.687~691 (2012)
14. Partridge AH, "Adherence to therapy with oral antineoplastic agents", J Natl Cancer Inst, 94(9), pp.652~661 (2002)
15. Choi JS, "Adherence to oral anticancer drugs in elderly cancer patients", pp.2011
16. Lee ER, "Patient compliance with oral anticancer drug medication and factors affecting compliance with medication", pp.2006
17. 김정혜, "대장암 환자의 경구용 항암제 복용이행과 영향요인", Asian Oncology Nursing, 12(3), pp.213~220 (2012), 대한종양간호학회
18. Cohen J, "Statistical power analysis for the behavioral sciences" (1977), Academic Press
19. Cleeland CS, "Assessing symptom distress in cancer patients: the M. D. Anderson Symptom Inventory", Cancer, 89(7), pp.1634~1646 (2000)
20. Yun YH, "Anderson Symptom Inventory", J Pain Symptom Manage, 31(4), pp.345~352 (2006)
21. Radloff LS, "The CES-D scale: a self-report depression scale for research in the general population", Appl Psychol Meas, 3, pp.385~401 (1977)
22. Cho MJ, "Diagnostic validity of the CES-D(Korean Version)in the assessment of DSM-Ⅲ-R Major Depression", J Korean Neuropsychiatr Assoc, 32(3), pp.381~399 (1993)
23. Heitzmann CA, "Assessing self-efficacy for coping with cancer : development and psychometric analysis of the brief version of the Cancer Behavior Inventory(CBI-B)", Psychooncology, 20(3), pp.302~312 (2011)
24. Zimet GD, "The multidimensional scale of perceived social support", J Pers Assess, 52(1), pp.30~41 (1988)
25. Morisky DE, "Predictive validity of a medication adherence measure in an outpatient setting", J Clin Hypertens(Greenwich), 10(5), pp.348~354 (2008)
26. Grunfeld EA, "Adherence beliefs among breast cancer patients taking tamoxifen", Patient Educ Couns, 59(1), pp.97~102 (2005)
27. Kirk MC, "Insight into barriers against optimal adherence to oral hormonal therapy in women with breast cancer", Clin Breast Cancer, 8(2), pp.155~161 (2008)
28. Lien CY, "Perceived uncertainty, social support and psychological adjustment in older patients with cancer being treated with surgery", Journal of Clinical Nursing, 18(16), pp.2311~2319 (2009)
29. Dimetto MR, "Depression is a risk factor for noncompliance with medical treatment", Arch Intern Med, 160(14), pp.2101~2107 (2000)
30. Darkow T, "Treatment interruptions and non-adherence with imatinib and associated healthcare costs : a retrospective analysis among managed care patients with chronic myelogenous leukaemia", Pharmacoeconomics, 25(6), pp.481~496 (2007)

관련 논문AI추천